LIPIDS-P Trial Phase I/II Trial
NCT03405870
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Sepsis, Severe
Septic Shock
Interventions
DRUG:
Smoflipid
Sponsor
University of Florida